Adempas-2.5mg (Riociguat Tablet) 2.5mg

Adempas 2.5mg tablets contain riociguat, a prescription medication used to treat pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. This 84-tablet pack supports consistent daily management of these conditions. Always follow healthcare provider guidance when using riociguat.

Strength

2.5mg

Pack Size

84s

Storage

Ambient

Manufacturer / TM Owner

MSD Sharp & Dohme

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Riociguat, the active ingredient in Adempas 2.5mg tablets, is prescribed to improve exercise capacity and reduce symptoms in adults with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. It belongs to a class of medications that help relax blood vessels in the lungs, supporting better blood flow. Patients often ask, 'what is riociguat used for' to understand its role in managing these specific conditions.

Side Effects

Adempas 2.5mg tablets may help reduce breathlessness and fatigue during daily activities by improving blood flow in the lungs. Some users report improved energy levels and reduced swelling in the legs. Individual responses vary, and effects are typically monitored by a healthcare professional. Regular use under medical supervision is recommended.

Precautions & Warnings

Riociguat can interact with other medications and may not be suitable for everyone. Inform your healthcare provider about all current medications, including over-the-counter products and supplements. Avoid smoking, as it may affect how riociguat works. Keep this medication in a cool, dry place away from children.

Avoid Interactions

Riociguat may interact with certain medications, including nitrates, PDE-5 inhibitors, and strong CYP3A4 inhibitors or inducers. Combining riociguat with these drugs can increase the risk of low blood pressure. Alcohol and grapefruit products may also affect how riociguat works. Always consult your doctor before starting or stopping any medications while taking riociguat.

Frequently Asked Questions

Riociguat is prescribed to treat pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension by improving blood flow in the lungs.

Store riociguat tablets at room temperature, away from moisture and direct sunlight, and keep them out of reach of children.

Consult your healthcare provider before combining riociguat with other drugs, as it may interact with certain medications like nitrates or PDE-5 inhibitors.

Common effects may include headache, dizziness, or upset stomach. Report any persistent or severe effects to your doctor.

Smoking may reduce the effectiveness of riociguat, so avoiding tobacco is recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.